July/August 2007 Vol 7 No 7 www.drugdeliverytech.com
IN THIS
ISSUE
INTERVIEW WITH
SENOPSYS LLC’S
FOUNDER & PRESIDENT
MR. JEFF
WORTHINGTON
Drug
Reconstitution
Graham Reynolds
24
Active & Passive
Transdermal
Systems 36
Ms. Cindy H. Dubin
Topical Delivery 46
Robert J. DeLuccia
FEATURING
Outsourcing
Formulation
Development
66
The science & business of specialty pharma, biotechnology, and drug delivery
Peptides &
Antibodies
Rodney Lappe, PhD
72
Mr. Diego
Gallardo
Álvarez
Comparison of
EUDRAGIT® FS 30 D
& L 30 D- 55 as
Matrix Formers in
SR Tablets
Ms. Cindy H.
Dubin
Assessing
Formulation
Development in
Specialty Pharma
Beth A-S
Brown, PhD
OraVescent®
Technology Offers
Greater Oral
Transmucosal
Delivery
Licensing
Strategies
Barath Shankar
76
